Imprimis Pharmaceuticals Announces National Account Agreement ...
PR Newswire (press release)-57 minutes ago
Imprimis' proprietary ophthalmic compounded formulations have been optimized for both injectable and topical applications compatible with the eye.
No comments:
Post a Comment